Evidence map›Paper›PMID 28179267›Full record

ReviewBMJ (Clinical research ed.)2017

Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child.

Patrick M Catalano, Kartik Shankar

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in BMJ (Clinical research ed.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 692 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
692citing papers in PubMed, 7 pooled it
72.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06064669 narecruitingstarted 2024, after this paper: background citation

Effect of Metformin on Healthy Live Birth After In-vitro Fertilization in Women With Prediabetes Mellitus: a Multicenter Double-blind Placebo Controlled Randomized Trial

Ran2024Enrolled988Registered outcomes26Posted comparisons0ConditionsIn-Vitro Fertilization, Metformin, PrediabetesArmsMetformin pretreatment before endometrial preparation for frozen embryo transfer, Metformin pretreatment before ovarian stimulation, Placebo pretreatment before endometrial preparation for frozen embryo transfer, Placebo pretreatment before ovarian stimulation
Open the trial in the graph
NCT04302168 nacompletednot on this mapstarted 2020, after this paper: background citation

Effects of Choline Supplementation on Fetal Growth in Gestational Diabetes Mellitus

TypeinterventionalSponsorMaimonides Medical CenterRan2020 to 2024Enrolled46ConditionsGestational DiabetesArmsCholine supplement, Placebo
3 · Its place in the literature

Who cites it

692 citing papers in PubMed, 7 syntheses or guidelines pooled it, 1,247 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Patient and public involvement in randomized trials of lifestyle intervention among pregnant women with obesity: An umbrella review.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2026
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Beyond Deterministic Fetal Programming: Intrauterine Exposures and the Multifactorial Origins of Adiposity.Obesity reviews : an official journal of the International Association for the Study of Obesity · 2026
    Review
  18. Article
  19. Article
  20. Placental Pathophysiology and Developmental Programming of Adult Cardiometabolic Risk: A Narrative Review of Pregnancy Exposures.Pathophysiology : the official journal of the International Society for Pathophysiology · 2026
    Review

632 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Patrick M CatalanoDepartment of Obstetrics and Gynecology, Center for Reproductive Health/MetroHealth Medical Center, Cleveland, Ohio, USA pcatalano@metrohealth.org.
Kartik ShankarArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Arkansas Children's Nutrition Center · USMetroHealth Medical Center · US

Funding

Zosuquidar trihydrochloride for acute myeloid leukemia &refractory anemiaM01RR000080 · NCRR · UNIVERSITY HOSPITALS OF CLEVELAND · PI DEARBORN, DORR GELLATLY · 1985 to 2007
$22.2M
INSULIN RESISTANCE AND GLUCOSE METABOLISM IN PREGNANCYR01HD022965 · NICHD · CASE WESTERN RESERVE UNIVERSITY · PI CATALANO, PATRICK · 1994 to 2011
$2.3M
NCRR NIH HHS M01 RR000080NICHD NIH HHS R01 HD022965
6 · The paper itself

Abstract

Obesity is the most common medical condition in women of reproductive age. Obesity during pregnancy has short term and long term adverse consequences for both mother and child. Obesity causes problems with infertility, and in early gestation it causes spontaneous pregnancy loss and congenital anomalies. Metabolically, obese women have increased insulin resistance in early pregnancy, which becomes manifest clinically in late gestation as glucose intolerance and fetal overgrowth. At term, the risk of cesarean delivery and wound complications is increased. Postpartum, obese women have an increased risk of venous thromboembolism, depression, and difficulty with breast feeding. Because 50-60% of overweight or obese women gain more than recommended by Institute of Medicine gestational weight guidelines, postpartum weight retention increases future cardiometabolic risks and prepregnancy obesity in subsequent pregnancies. Neonates of obese women have increased body fat at birth, which increases the risk of childhood obesity. Although there is no unifying mechanism responsible for the adverse perinatal outcomes associated with maternal obesity, on the basis of the available data, increased prepregnancy maternal insulin resistance and accompanying hyperinsulinemia, inflammation, and oxidative stress seem to contribute to early placental and fetal dysfunction. We will review the pathophysiology underlying these data and try to shed light on the specific underlying mechanisms.

Indexed as

ObesityPregnancy ComplicationsDisease ManagementFemaleHumansInfant, NewbornPregnancyPregnancy OutcomeTime

Identifiers

PMID28179267
PMCPMC6888512
OpenAlexW2586570290

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.